A Comparison of Additional Benefit Scores in Germany (Gba) and France (Has)

Value in Health - United Kingdom
doi 10.1016/j.jval.2014.08.1092
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Php42 - Early Access Programs: A Comparison Between France, Germany and the United Kingdom

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

France, Germany and Europe

European Review
DevelopmentPlanningInternational RelationsPolitical ScienceGeography
2002English

Criminal Statistics in Germany, France and England

Journal of the American Institute of Criminal Law and Criminology
1910English

Cohabiting Unions in France and West Germany

Demographic Research
Demography
2002English

Trade and Technical Education in France and Germany

Nature
Multidisciplinary
1914English

Is the Proof of an Additional Benefit Under Amnog in Germany More Difficult for Certain Drugs Than for Other Ones?

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2015English

Procedures and Methods of Benefit Assessments for Medicines in Germany

European Journal of Health Economics
Health PolicyEconomicsEconometricsFinance
2008English

Institutionalizing Dualism: Complementarities and Change in France and Germany

Politics and Society
SociologyInternational RelationsSocial SciencesPolitical Science
2010English

Embedded Collectivism? Workplace Representation in France and Germany

Industrial Relations Journal
Industrial Relations
2006English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy